Diabetes and atrial fibrillation in hospitalized patients in the United States

Background Data on the burden of atrial fibrillation (AF) associated with diabetes among hospitalized patients are scarce. We assessed the AF‐related hospitalizations trends in patients with diabetes, and compared AF outcomes in patients with diabetes to those without diabetes. Hypothesis AF‐related...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Clinical cardiology (Mahwah, N.J.) Ročník 44; číslo 3; s. 340 - 348
Hlavní autori: Kumar, Nilay, Echouffo‐Tcheugui, Justin B.
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: New York Wiley Periodicals, Inc 01.03.2021
John Wiley & Sons, Inc
Predmet:
Ablation
Age
Anemia
atrial fibrillation
Atrial Fibrillation - diagnosis
Atrial Fibrillation - epidemiology
Atrial Fibrillation - therapy
Cardiac arrhythmia
Cardioversion
Catheters
Clinical Investigations
Codes
Comorbidity
Diabetes
diabetes mellitus
Diabetes Mellitus - diagnosis
Diabetes Mellitus - epidemiology
Diabetes Mellitus - therapy
Fatalities
Heart failure
Hospitalization
Humans
Hypertension
Length of Stay
Lung diseases
Pacemakers
Patient Readmission
Rehabilitation
Trends
United States - epidemiology
Variables
United States
United States > US
atrial fibrillation
diabetes mellitus
trends
ISSN:0160-9289, 1932-8737, 1932-8737
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:Background Data on the burden of atrial fibrillation (AF) associated with diabetes among hospitalized patients are scarce. We assessed the AF‐related hospitalizations trends in patients with diabetes, and compared AF outcomes in patients with diabetes to those without diabetes. Hypothesis AF‐related health outcomes differ between patient with diabetes and without diabetes. Methods Using the National Inpatient Sample (NIS) 2004–2014, we studied trends in AF hospitalization rate among diabetic patients, and compared in‐hospital case fatality rate, length of stay (LOS), cost and utilization of rhythm control therapies, and 30‐day readmission rate between patients with and without diabetes. Logistic or Cox regression models were used to assess the differences in AF outcomes by diabetes status. Results Over the study period, there were 4 325 522 AF‐related hospitalizations, of which 1 075 770 (24.9%) had a diagnosis of diabetes. There was a temporal increase in AF hospitalization rate among diabetic patients (10.4 to 14.4 per 1000 hospitalizations among patients with diabetes; +4.4% yearly change, p‐trend < .0001). Among AF patients, those with diabetes had a lower in‐hospital mortality (adjusted odds ratio [aOR]: 0.68; 95% CI: 0.65–0.72) and LOS (aOR: 0.95; 95% CI: 0.94–0.96), but no difference in costs (aOR: 0.95; 95% CI: 0.94–0.96) and a higher 30‐day rate of readmissions compared with no diabetes (aHR 1.05; 95% CI: 1.01–1.08), compared to individuals without diabetes. Conclusion AF and diabetes coexist among hospitalized patients, with rising trends over the last decade. Diabetes is associated with lower rates in‐hospital adverse AF outcomes, but a higher 30‐day readmission risk.
Bibliografia:Nilay Kumar and Justin B. Echouffo Tcheugui equally to this study.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0160-9289
1932-8737
1932-8737
DOI:10.1002/clc.23533